JPS5238680B2
(es)
|
1972-12-27 |
1977-09-30 |
|
|
US4732155A
(en)
|
1985-08-27 |
1988-03-22 |
The Children's Medical Center Corporation |
Implantable chemoattractant system
|
US5658894A
(en)
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
US5661127A
(en)
|
1995-05-01 |
1997-08-26 |
The Regents Of The University Of California |
Peptide compositions with growth factor-like activity
|
JP3018313B2
(ja)
|
1996-02-23 |
2000-03-13 |
雪印乳業株式会社 |
骨形成促進及び骨吸収防止剤
|
US6875753B1
(en)
|
1996-03-14 |
2005-04-05 |
The Governors Of The University Of Alberta |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
US20050113335A1
(en)
|
1996-04-02 |
2005-05-26 |
Pilarski Linda M. |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
ES2299241T3
(es)
|
1998-03-17 |
2008-05-16 |
Chugai Seiyaku Kabushiki Kaisha |
Preventivos o remedios para enfermedades intestinales inflamatorias que contienen anticuerpos antagonistas del receptor il-6.
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
CA2380052C
(en)
|
1999-07-28 |
2007-10-23 |
John Cooke |
Nicotine receptor agonists in stem cell and progenitor cell recruitment
|
JP2003517858A
(ja)
|
1999-11-05 |
2003-06-03 |
ジェリジーン メディカル コーポレーション |
老齢関連の軟組織の欠陥の増強と修復
|
EP1114862A3
(de)
|
1999-11-17 |
2003-08-06 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
|
DE60130435T2
(de)
|
2000-02-24 |
2009-07-23 |
Invitrogen Corp., Carlsbad |
Gleichzeitige stimulation und konzentration von zellen
|
JP3421741B2
(ja)
|
2000-05-18 |
2003-06-30 |
筑波大学長 |
人工骨髄、血球細胞の増殖方法
|
US7754217B2
(en)
|
2001-03-16 |
2010-07-13 |
Bio3 Research Srl |
HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
|
EP1390058A2
(en)
|
2001-04-30 |
2004-02-25 |
Switch Biotech Aktiengesellschaft |
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
|
DE10121254A1
(de)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
CA2447576C
(en)
|
2001-05-15 |
2014-04-08 |
North Shore-Long Island Jewish Research Institute |
Use of hmg fragments as anti-inflammatory agents
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
WO2003043651A1
(en)
|
2001-11-19 |
2003-05-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Drug mobilizing pluripotent stem cells from tissue into peripheral blood
|
WO2003053346A2
(en)
|
2001-12-07 |
2003-07-03 |
Macropore Biosurgery, Inc. |
Systems and methods for treating patients with processed lipoaspirate cells
|
FR2833609B1
(fr)
|
2001-12-19 |
2004-12-03 |
Natural Implant |
Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations
|
CA2491321A1
(en)
|
2002-07-03 |
2004-01-15 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair
|
WO2004004770A1
(en)
|
2002-07-05 |
2004-01-15 |
Universite Laval |
Chemotactic factor inhibitor for modulating inflammatory reactions
|
WO2004042033A2
(en)
|
2002-11-01 |
2004-05-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circulating stem cells and uses related thereto
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
EP1569684A4
(en)
|
2002-11-20 |
2006-08-02 |
Critical Therapeutics Inc |
USE OF HMGB FRAGMENTS AS ANTI-INFLAMMATORY AGENTS
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
US7470538B2
(en)
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
CA2512512A1
(en)
|
2003-01-03 |
2004-07-22 |
Alcedo Biotech Gmbh |
Uses of hmgb, hmgn, hmga proteins
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
CN1193092C
(zh)
|
2003-03-28 |
2005-03-16 |
浙江大学 |
骨髓间充质干细胞分离和体外扩增培养方法
|
DE602004017148D1
(de)
|
2003-03-28 |
2008-11-27 |
Univ Laval |
S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
|
US20090069227A9
(en)
|
2003-04-29 |
2009-03-12 |
Capogrossi Maurizio C |
Use of HMGB1 to promote stem cell migration and/or proliferation
|
JP2007535486A
(ja)
|
2003-05-07 |
2007-12-06 |
ラ ホーヤ インスティチュート フォー モレキュラー メディシン |
高分子量のヒアルロン酸を用いた内因性又は埋め込まれた又は移植された幹細胞の機能回復を促進するための方法
|
US20050014255A1
(en)
|
2003-05-29 |
2005-01-20 |
Board Of Regents, The University Of Texas System |
Stem cells for clinical and commercial uses
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
ITRM20040058A1
(it)
|
2004-02-03 |
2004-05-03 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
|
AU2005264185A1
(en)
|
2004-07-20 |
2006-01-26 |
Centro Cardiologico Monzino S.P.A. - Irccs |
Use of HMGB1 for wound healing
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
KR101249287B1
(ko)
|
2004-09-03 |
2013-04-01 |
크리어빌리스 쎄라퓨틱스 에스.피.에이. |
인간 및 비인간 hmgb1 boxa의 단백질분해효소내성 돌연변이 및 그들의 치료/진단 용도
|
EP1812065A4
(en)
|
2004-10-22 |
2009-09-02 |
Medimmune Inc |
HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE
|
KR100593397B1
(ko)
|
2004-10-27 |
2006-06-28 |
한국원자력연구소 |
중배엽 줄기세포 및/또는 p 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
|
WO2006047820A1
(en)
|
2004-11-01 |
2006-05-11 |
Newsouth Innovations Pty Limited |
Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
|
ITRM20050032A1
(it)
|
2005-01-21 |
2006-07-22 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
|
WO2006080434A1
(ja)
|
2005-01-27 |
2006-08-03 |
Japan Health Sciences Foundation |
間葉系幹細胞を含む細胞シート
|
ES2345837T3
(es)
|
2005-03-23 |
2010-10-04 |
Biosafe S.A. |
Sistema integrado para la recogida, el procesamiento y el trasplante de subgrupos de celulas, incluyendo celulas madre adultas, para medicina regenerativa.
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
US20100280493A1
(en)
|
2005-06-23 |
2010-11-04 |
Asha Nayak |
Methods and Systems for Treating Injured Cardiac Tissue
|
US20100040608A1
(en)
|
2005-07-18 |
2010-02-18 |
Marie Wahren-Herlenius |
Use of HMGB1 antagonists for the treatment of inflammatory skin conditions
|
WO2007015546A1
(ja)
|
2005-08-04 |
2007-02-08 |
Genomix Co., Ltd |
間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
|
WO2007031100A1
(en)
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
US20090155853A1
(en)
|
2005-11-18 |
2009-06-18 |
Gary Nabel |
Non-viral gene delivery complex
|
CA2631212A1
(en)
|
2005-11-28 |
2007-07-05 |
Medimmune, Llc |
Antagonists of hmgb1 and/or rage and methods of use thereof
|
WO2007087367A2
(en)
|
2006-01-25 |
2007-08-02 |
Mount Sinai School Of Medicine |
Methods and compositions for modulating the mobilization of stem cells
|
US7829097B2
(en)
*
|
2006-02-06 |
2010-11-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Use of HMGB1 for protection against ischemia reperfusion injury
|
JP4982739B2
(ja)
|
2006-06-01 |
2012-07-25 |
国立大学法人 東京医科歯科大学 |
ポリグルタミン病の予防・治療剤
|
JP5244785B2
(ja)
|
2006-08-11 |
2013-07-24 |
小野薬品工業株式会社 |
ストローマ由来因子−1(sdf−1)に対するモノクローナル抗体
|
PL2068935T3
(pl)
|
2006-09-15 |
2011-11-30 |
Creabilis Therapeutics S R L |
Polimerowe koniugaty BOX-A HMGB1 i warianty HMGB1
|
DK2055308T3
(en)
|
2006-10-30 |
2017-07-17 |
Genomix Co Ltd |
PHARMACEUTICALS FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED TISSUE
|
CA2629652A1
(en)
|
2007-04-24 |
2008-10-24 |
Yaojiong Wu |
Compositions for preventing or treating skin defects and methods of use thereof
|
US8114668B2
(en)
|
2007-05-14 |
2012-02-14 |
Cardiac Pacemakers, Inc. |
Composition for cold storage of stem cells
|
RU2010148785A
(ru)
|
2008-04-30 |
2012-06-10 |
Дженомикс Ко., Лтд. (Jp) |
Фармацевтическое средство для стимуляции функциональной регенерации поврежденной ткани
|
JP5660889B2
(ja)
|
2008-04-30 |
2015-01-28 |
株式会社ジェノミックス |
末梢循環への骨髄由来多能性幹細胞動員薬
|
US9919010B2
(en)
|
2008-04-30 |
2018-03-20 |
Genomix Co., Ltd. |
Method for collecting functional cells in vivo with high efficiency
|
JP2013508013A
(ja)
|
2009-10-16 |
2013-03-07 |
ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー |
細胞療法戦略を用いた慢性神経組織損傷の治療方法
|
WO2011049810A2
(en)
|
2009-10-20 |
2011-04-28 |
Maine Medical Center |
Compositions and methods for treating inflammation and fibrosis
|
AU2010312537A1
(en)
|
2009-10-28 |
2012-05-17 |
Genomix Co., Ltd. |
Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
|
US9285378B2
(en)
*
|
2010-01-29 |
2016-03-15 |
Metanomics Gmbh |
Means and methods for diagnosing heart failure in a subject
|
CN102247392A
(zh)
*
|
2010-05-21 |
2011-11-23 |
中国医学科学院药物研究所 |
甘草酸治疗扩张型心肌病心脏重构和心功能障碍的用途
|
JP5950428B2
(ja)
|
2010-08-05 |
2016-07-13 |
日東電工株式会社 |
線維化組織から正常組織を再生するための組成物
|
EP2613797B1
(en)
|
2010-09-09 |
2015-11-04 |
University Of Southern California |
Compositions and methods for the removal of biofilms
|
ES2684718T3
(es)
|
2011-04-26 |
2018-10-04 |
StemRIM Inc. |
Péptido para inducir regeneración de tejido y uso del mismo
|
CN102443064A
(zh)
|
2011-11-03 |
2012-05-09 |
刘誉 |
一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
|
WO2014016417A1
(en)
|
2012-07-26 |
2014-01-30 |
Ospedale San Raffaele Srl |
Hmgb1 variants and uses thereof
|
KR101448800B1
(ko)
|
2012-10-24 |
2014-10-13 |
한양대학교 산학협력단 |
핵산 전달 복합체
|
RU2649069C2
(ru)
|
2012-10-25 |
2018-04-02 |
Дженомикс Ко., Лтд. |
Новый способ лечения повреждения спинного мозга с применением фрагмента hmgb1
|
CA2889275C
(en)
|
2012-10-25 |
2021-06-15 |
Katsuto Tamai |
Novel method for treating cardiac infarction using hmgb1 fragment
|
GB2514424A
(en)
*
|
2013-05-25 |
2014-11-26 |
Univ Dublin |
Therapies for Cardiomyopathy
|
KR101636139B1
(ko)
|
2013-08-28 |
2016-07-06 |
가톨릭대학교 산학협력단 |
면역조절능이 우수한 sRAGE 과발현 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
|
GB201508337D0
(en)
|
2015-05-15 |
2015-06-24 |
Hmgbiotech S R L |
Novel peptides
|
TWI805565B
(zh)
|
2017-01-27 |
2023-06-21 |
日商斯德武利姆股份有限公司 |
心肌病、陳舊性心肌梗塞及慢性心臟衰竭的治療藥物
|
EP3607963A4
(en)
|
2017-04-07 |
2021-01-06 |
Stemrim Inc. |
THERAPEUTIC DRUG FOR FIBROUS DISEASES
|
CN111868231B
(zh)
|
2017-12-01 |
2024-05-31 |
斯特姆里姆有限公司 |
外胚层间充质干细胞及其产生方法
|
WO2019107530A1
(ja)
|
2017-12-01 |
2019-06-06 |
株式会社ステムリム |
炎症性腸疾患の治療薬
|
EP3750553A4
(en)
|
2018-02-08 |
2022-01-12 |
Stemrim Inc. |
THERAPEUTIC FOR PSORIASIS
|
US20210347839A1
(en)
|
2018-10-05 |
2021-11-11 |
StemRIM Inc. |
Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization
|
EP3862017A4
(en)
|
2018-10-05 |
2022-08-03 |
Stemrim Inc. |
PEPTIDE WITH MESENCHYMAL STEM CELL MOBILIZATION ACTIVITY
|
JPWO2020158924A1
(ja)
|
2019-01-31 |
2021-12-02 |
国立大学法人大阪大学 |
母児間免疫寛容を誘導する方法
|
US20220265787A1
(en)
|
2019-07-31 |
2022-08-25 |
StemRIM Inc. |
Composition for promoting growth or suppressing decrease of mesenchymal stem cells
|
JPWO2021201260A1
(es)
|
2020-04-03 |
2021-10-07 |
|
|